Pro Share Advisors LLC Instil Bio, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.6 - $0.91 $1,500 - $2,275	-2,501 Reduced 12.7%	17,186 $11,000
Q4 2022 Feb 02, 2023	BUY	$0.48 - $5.33 $530 - $5,889	1,105 Added 5.95%	19,687 $12,000
Q3 2022 Nov 04, 2022	BUY	$4.65 - $7.37 $3,236 - $5,129	696 Added 3.89%	18,582 $90,000
Q2 2022 Aug 01, 2022	SELL	$4.21 - $11.15 $23,554 - $62,384	-5,595 Reduced 23.83%	17,886 $83,000
Q1 2022 May 10, 2022	SELL	$8.48 - $18.1 $55,136 - $117,686	-6,502 Reduced 21.69%	23,481 $251,000
Q4 2021 Feb 08, 2022	BUY	$15.37 - $22.5 $460,838 - $674,617	29,983 New	29,983 $514,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.